Tang H, Kimmel SE, Smith SM, Cusi K, et al. Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials. Diabetes Care 2022;45:1007-1012.
PMID: 35349656